MergerLinks - ENTASIS THERAPEUTICS LIMITED / TPG BIOTECHNOLOGY PARTNERS V L.P. / SOFINNOVA VENTURE PARTNERS IX LP / PIVOTAL BIOVENTURE PARTNERS LLC / NOVO A/S / FRAZIER LIFE SCIENCES VIII LP / EVENTIDE HEALTHCARE & LIFE SCIENCES FUND / EVENTIDE GILEAD FUND / CLARUS VENTURES LLC / Acquisition / Private / £44m

Announced

5 Sep 2017

Completed

5 Sep 2017

ENTASIS THERAPEUTICS LIMITED / TPG BIOTECHNOLOGY PARTNERS V L.P. / SOFINNOVA VENTURE PARTNERS IX LP / PIVOTAL BIOVENTURE PARTNERS LLC / NOVO A/S / FRAZIER LIFE SCIENCES VIII LP / EVENTIDE HEALTHCARE & LIFE SCIENCES FUND / EVENTIDE GILEAD FUND / CLARUS VENTURES LLC / Acquisition / Private / £44m

Financials

Transaction Value-

Consideration Type-

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

Entasis Therapeutics

Clarus Ventures

Eventide Gilead Fund

Eventide Healthcare & Life Sciences Fund

Frazier Life Sciences Viii

Novo Holdings

Pivotal Bioventure Partners

Tpg Biotechnology Partners V

Sofinnova Partners

Sources